Oramed Pharmaceuticals Inc. SEC filings ORMP
Oramed Pharmaceuticals Inc. has 941 filings in SEC EDGAR's recent list, going back to Nov 29, 2002. Its latest annual report, Form ARS, was filed on Aug 3, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 10, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 17, 2026 (shareholder vote results). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| NT 10-Q | Notification of late filing | May 15, 2026 | Mar 31, 2026 |
| 8-A12B | For registration of certain classes | Nov 17, 2025 | — |
| EFFECT | Filing | Jul 26, 2021 | — |
| CORRESP | Letter to the SEC | Jul 22, 2021 | — |
| UPLOAD | Letter from the SEC | Jul 21, 2021 | — |
| EFFECT | Filing | Feb 10, 2021 | — |
| UPLOAD | Letter from the SEC | Feb 9, 2021 | — |
| CORRESP | Letter to the SEC | Feb 9, 2021 | — |
| CT ORDER | Filing | May 1, 2020 | — |
| CT ORDER | Filing | May 1, 2020 | — |
| EFFECT | Filing | Feb 10, 2020 | — |
| CORRESP | Letter to the SEC | Feb 6, 2020 | — |
| UPLOAD | Letter from the SEC | Feb 4, 2020 | — |
| CT ORDER | Filing | Apr 16, 2018 | — |
| UPLOAD | Letter from the SEC | Jul 28, 2017 | — |
| PRER14A | Preliminary revised proxy soliciting materials | Jul 28, 2017 | — |
| UPLOAD | Letter from the SEC | Mar 3, 2017 | — |
| CORRESP | Letter to the SEC | Feb 21, 2017 | — |
| UPLOAD | Letter from the SEC | Feb 10, 2017 | — |
| EFFECT | Filing | Feb 2, 2017 | — |
| CORRESP | Letter to the SEC | Jan 31, 2017 | — |
| UPLOAD | Letter from the SEC | Jan 25, 2017 | — |
| CT ORDER | Filing | Jan 17, 2017 | — |
| CT ORDER | Filing | Feb 17, 2016 | — |
| CT ORDER | Filing | Dec 9, 2014 | — |
| D | Filing | Nov 14, 2014 | — |
| UPLOAD | Letter from the SEC | Jun 17, 2014 | — |
| CORRESP | Letter to the SEC | Jun 16, 2014 | — |
| UPLOAD | Letter from the SEC | Jun 12, 2014 | — |
| EFFECT | Filing | Apr 10, 2014 | — |
| CORRESP | Letter to the SEC | Apr 9, 2014 | — |
| UPLOAD | Letter from the SEC | Apr 4, 2014 | — |
| CORRESP | Letter to the SEC | Mar 4, 2014 | — |
| CORRESP | Letter to the SEC | Feb 18, 2014 | — |
| UPLOAD | Letter from the SEC | Feb 5, 2014 | — |
| UPLOAD | Letter from the SEC | Feb 5, 2014 | — |
| EFFECT | Filing | Aug 22, 2013 | — |
| NT 10-Q | Filing | Jul 16, 2013 | May 31, 2013 |
| EFFECT | Filing | Mar 22, 2013 | — |
| EFFECT | Filing | Feb 12, 2013 | — |
| CERTNAS | Auto-generated paper document | Feb 8, 2013 | — |
| 8-A12B | Filing | Feb 7, 2013 | — |
| CT ORDER | Filing | Jan 8, 2013 | — |
| D | Filing | Jan 3, 2013 | — |
| D | Filing | Jan 2, 2013 | — |
| NT 10-K | Filing | Nov 29, 2012 | Aug 31, 2012 |
| D/A | Filing | Sep 27, 2012 | — |
| D/A | Filing | Sep 19, 2012 | — |
| D | Filing | Sep 12, 2012 | — |
| EFFECT | Filing | Feb 24, 2012 | — |
| EFFECT | Filing | Jul 11, 2011 | — |
| D/A | Filing | Apr 13, 2011 | — |
| EFFECT | Filing | Apr 11, 2011 | — |
| D/A | Filing | Feb 22, 2011 | — |
| D | Filing | Jan 18, 2011 | — |
| EFFECT | Filing | Sep 15, 2010 | — |
| RW | Filing | Aug 31, 2010 | — |
| EFFECT | Filing | Mar 3, 2010 | — |
| CORRESP | Letter to the SEC | Mar 3, 2010 | — |
| UPLOAD | Letter from the SEC | Jan 27, 2010 | — |
| EFFECT | Filing | Jan 12, 2010 | — |
| 10KSB | Filing | Nov 26, 2008 | Aug 31, 2008 |
| REGDEX | Auto-generated paper document | Jul 22, 2008 | — |
| 10QSB | Filing | Jul 21, 2008 | May 31, 2008 |
| NT 10-Q | Filing | Jul 16, 2008 | May 31, 2008 |
| 10QSB | Filing | Apr 14, 2008 | Feb 29, 2008 |
| 10QSB | Quarterly report for the period ended november 30, 2007 | Jan 14, 2008 | Nov 30, 2007 |
| EFFECT | Filing | Jan 11, 2008 | — |
| CORRESP | Letter to the SEC | Jan 9, 2008 | — |
| SB-2/A | Amendmend to the registration statement | Jan 8, 2008 | — |
| UPLOAD | Letter from the SEC | Jan 2, 2008 | — |
| SB-2 | Registration statement | Dec 19, 2007 | — |
| 10KSB | Filing | Dec 12, 2007 | Aug 31, 2007 |
| NT 10-K | Filing | Nov 29, 2007 | Aug 31, 2007 |
| 10QSB | Filing | Jul 23, 2007 | May 31, 2007 |
| NT 10-Q | Filing | Jul 17, 2007 | May 31, 2007 |
| 10QSB | Report for the quarterly period ended february 28, 2007 | Apr 23, 2007 | Feb 28, 2007 |
| NT 10-Q | Filing | Apr 16, 2007 | Feb 28, 2007 |
| 10QSB | Form 10-qsb (november 30, 2006) | Jan 22, 2007 | Nov 30, 2006 |
| NT 10-Q | Form nt | Jan 16, 2007 | Nov 30, 2006 |
| 10KSB | Form 10-ksb (august 31, 2006) | Dec 14, 2006 | Aug 31, 2006 |
| NT 10-K | Form nt 10-k | Nov 29, 2006 | Aug 31, 2006 |
| 10QSB | Form 10-qsb | Jul 17, 2006 | May 31, 2006 |
| 10QSB | Form 10-qsb | May 19, 2006 | Feb 28, 2006 |
| SC 14F1 | Schedule 14f1 | Feb 23, 2006 | — |
| 10KSB/A | Form 10-ksb/a | Feb 23, 2006 | Aug 31, 2005 |
| 10QSB | Integrated security technologies, inc. form 10-qsb for period ended november 30, | Jan 4, 2006 | Nov 30, 2005 |
| 10KSB | Integrated security technologies, inc. form 10-ksb for year ended 8-31-2005 | Nov 4, 2005 | Aug 31, 2005 |
| 10KSB/A | Integrated securities technologies, inc. form 10ksb/a 8-31-04 | Jul 29, 2005 | Aug 31, 2004 |
| 10QSB/A | Integrated securities technologies, inc. form 10 qsb/a 2-28-05 | Jul 29, 2005 | Feb 28, 2005 |
| 10QSB/A | Integrated securities technologies, inc. 10qsb/a 5-31-04 | Jul 29, 2005 | May 31, 2004 |
| 10QSB/A | Integrated securities technologies, inc. 10qsb/a 5-31-05 | Jul 28, 2005 | May 31, 2005 |
| 10QSB/A | Integrated securities technologies, inc. 10qsb/a 11-30-04 | Jul 28, 2005 | Nov 30, 2004 |
| 10QSB | Form 10qsb 5-31-05 | Jul 26, 2005 | May 31, 2005 |
| NTN 10Q | Integrated securities technologies, inc. form nt10q 5-31-05 | Jul 19, 2005 | May 31, 2005 |
| 10QSB | Iguana ventures ltd. form 10qsb 2-28-2005 | Jul 13, 2005 | Feb 28, 2005 |
| 10QSB | Iguana ventures ltd. form 10qsb 11-30-2004 | Jul 12, 2005 | Nov 30, 2004 |
| 10QSB | Iguana ventures ltd. form 10qsb 5-31-2004 | Jul 12, 2005 | May 31, 2004 |
| 10KSB | Iguana ventures ltd. form 10ksb 8-31-2004 | Jul 12, 2005 | Aug 31, 2004 |
| NT 10-K | Filing | Sep 28, 2004 | Jun 30, 2004 |
| REGDEX | Auto-generated paper document | Jul 8, 2004 | — |
| 10QSB | Quarterly report for the period ending february 29, 2004 | Apr 19, 2004 | Feb 29, 2004 |
| NT 10-Q | Notification of late filing for the year ended february 29, 2004 | Apr 15, 2004 | Feb 29, 2004 |
| 10QSB | Quarterly report for the period ending november 30, 2003 | Jan 20, 2004 | Nov 30, 2003 |
| NT 10-Q | Notification of late filing for the period ended november 30, 2003 | Jan 15, 2004 | Nov 30, 2003 |
| 10KSB | Annual report for the fiscal period ended august 31, 2003 | Dec 1, 2003 | Aug 31, 2003 |
| 10QSB | Iguana 10-qsb | Jul 25, 2003 | May 31, 2003 |
| SB-2/A | Filing | Jun 5, 2003 | — |
| 8-A12G | Filing | May 29, 2003 | — |
| SB-2/A | Filing | May 8, 2003 | — |
| SB-2/A | Filing | May 7, 2003 | — |
| SB-2/A | Filing | Feb 12, 2003 | — |
| SB-2 | Filing | Nov 29, 2002 | — |
Showing 113 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- ORMP (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- New York, NY
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1176309
- Former names
- Integrated Security Technologies, Inc. (until Apr 10, 2006); IGUANA VENTURES LTD (until Jun 10, 2004)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.